BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

541 related articles for article (PubMed ID: 21455322)

  • 21. Management of ascites in patients with liver cirrhosis: recent evidence and controversies.
    Hsu SJ; Huang HC
    J Chin Med Assoc; 2013 Mar; 76(3):123-30. PubMed ID: 23497963
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Pathophysiology, diagnosis and treatment of ascites in cirrhosis.
    Arroyo V
    Ann Hepatol; 2002; 1(2):72-9. PubMed ID: 15115971
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Transjugular intrahepatic portosystemic shunting versus paracentesis plus albumin for refractory ascites in cirrhosis.
    Ginès P; Uriz J; Calahorra B; Garcia-Tsao G; Kamath PS; Del Arbol LR; Planas R; Bosch J; Arroyo V; Rodés J
    Gastroenterology; 2002 Dec; 123(6):1839-47. PubMed ID: 12454841
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Progress in treatment of massive ascites and hepatorenal syndrome.
    Gerbes AL; Gulberg V
    World J Gastroenterol; 2006 Jan; 12(4):516-9. PubMed ID: 16489662
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Liver-HERO: hepatorenal syndrome-acute kidney injury (HRS-AKI) treatment with transjugular intrahepatic portosystemic shunt in patients with cirrhosis-a randomized controlled trial.
    Ripoll C; Platzer S; Franken P; Aschenbach R; Wienke A; Schuhmacher U; Teichgräber U; Stallmach A; Steighardt J; Zipprich A;
    Trials; 2023 Apr; 24(1):258. PubMed ID: 37020315
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Treatment for ascites in adults with decompensated liver cirrhosis: a network meta-analysis.
    Benmassaoud A; Freeman SC; Roccarina D; Plaz Torres MC; Sutton AJ; Cooper NJ; Iogna Prat L; Cowlin M; Milne EJ; Hawkins N; Davidson BR; Pavlov CS; Thorburn D; Tsochatzis E; Gurusamy KS
    Cochrane Database Syst Rev; 2020 Jan; 1(1):CD013123. PubMed ID: 31978257
    [TBL] [Abstract][Full Text] [Related]  

  • 27. AGA Clinical Practice Update on the Evaluation and Management of Acute Kidney Injury in Patients With Cirrhosis: Expert Review.
    Flamm SL; Wong F; Ahn J; Kamath PS
    Clin Gastroenterol Hepatol; 2022 Dec; 20(12):2707-2716. PubMed ID: 36075500
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Fluid retention in cirrhosis: pathophysiology and management.
    Kashani A; Landaverde C; Medici V; Rossaro L
    QJM; 2008 Feb; 101(2):71-85. PubMed ID: 18184668
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Ascites and spontaneous bacterial peritonitis in patients with liver cirrhosis.
    van Erpecum KJ
    Scand J Gastroenterol Suppl; 2006; (243):79-84. PubMed ID: 16782626
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Management of ascites in children.
    Lane ER; Hsu EK; Murray KF
    Expert Rev Gastroenterol Hepatol; 2015; 9(10):1281-92. PubMed ID: 26325252
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Translating Our Current Understanding of Ascites Management into New Therapies for Patients with Cirrhosis and Fluid Retention.
    Pose E; Cardenas A
    Dig Dis; 2017; 35(4):402-410. PubMed ID: 28468013
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Chinese guidelines on the management of ascites and its related complications in cirrhosis.
    ; Xu X; Duan Z; Ding H; Li W; Jia J; Wei L; Linghu E; Zhuang H
    Hepatol Int; 2019 Jan; 13(1):1-21. PubMed ID: 30656520
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Comparison of the effect of terlipressin and albumin on arterial blood volume in patients with cirrhosis and tense ascites treated by paracentesis: a randomised pilot study.
    Moreau R; Asselah T; Condat B; de Kerguenec C; Pessione F; Bernard B; Poynard T; Binn M; Grangé JD; Valla D; Lebrec D
    Gut; 2002 Jan; 50(1):90-4. PubMed ID: 11772973
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Management of ascites in cirrhosis.
    Sandhu BS; Sanyal AJ
    Clin Liver Dis; 2005 Nov; 9(4):715-32, viii. PubMed ID: 16207572
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Ascites, hepatorenal syndrome and spontaneous bacterial peritonitis in patients with portal hypertension].
    Kim YS
    Korean J Gastroenterol; 2010 Sep; 56(3):168-85. PubMed ID: 20847607
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Management of uninfected and infected ascites in cirrhosis.
    Solà E; Solé C; Ginès P
    Liver Int; 2016 Jan; 36 Suppl 1():109-15. PubMed ID: 26725907
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Update on peripheral arterial vasodilation, ascites and hepatorenal syndrome in cirrhosis.
    Knotek M; Rogachev B; Schrier RW
    Can J Gastroenterol; 2000 Nov; 14 Suppl D():112D-121D. PubMed ID: 11110623
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Treatment of cirrhotic ascites.
    Schouten J; Michielsen PP
    Acta Gastroenterol Belg; 2007; 70(2):217-22. PubMed ID: 17715638
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Management of ascites. Paracentesis as a guide.
    Habeeb KS; Herrera JL
    Postgrad Med; 1997 Jan; 101(1):191-2, 195-200. PubMed ID: 9008697
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Treatment of ascites in cirrhosis. Diuretics, peritoneovenous shunt, and large-volume paracentesis.
    Arroyo V; Ginès P; Planas R
    Gastroenterol Clin North Am; 1992 Mar; 21(1):237-56. PubMed ID: 1568775
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 28.